TW200817011A - Aerosol formulation for the inhalation of beta agonists - Google Patents

Aerosol formulation for the inhalation of beta agonists Download PDF

Info

Publication number
TW200817011A
TW200817011A TW096130614A TW96130614A TW200817011A TW 200817011 A TW200817011 A TW 200817011A TW 096130614 A TW096130614 A TW 096130614A TW 96130614 A TW96130614 A TW 96130614A TW 200817011 A TW200817011 A TW 200817011A
Authority
TW
Taiwan
Prior art keywords
acid
active substance
ethyl
enantiomers
mixture
Prior art date
Application number
TW096130614A
Other languages
English (en)
Chinese (zh)
Inventor
Kirsten Radau
Michael Aven
Rainer Weitzel
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of TW200817011A publication Critical patent/TW200817011A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
TW096130614A 2006-08-18 2007-08-17 Aerosol formulation for the inhalation of beta agonists TW200817011A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06119131 2006-08-18
EP07101129 2007-01-25

Publications (1)

Publication Number Publication Date
TW200817011A true TW200817011A (en) 2008-04-16

Family

ID=38521160

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096130614A TW200817011A (en) 2006-08-18 2007-08-17 Aerosol formulation for the inhalation of beta agonists

Country Status (18)

Country Link
US (2) US20080041369A1 (und)
EP (1) EP2054084A1 (und)
JP (1) JP2010501022A (und)
KR (1) KR20090057393A (und)
AR (1) AR062425A1 (und)
AU (1) AU2007285747A1 (und)
BR (1) BRPI0715761A2 (und)
CA (1) CA2660488A1 (und)
CO (1) CO6170341A2 (und)
IL (1) IL197025A0 (und)
MX (1) MX2009001759A (und)
NO (1) NO20090407L (und)
NZ (1) NZ575425A (und)
PE (1) PE20081319A1 (und)
SG (1) SG174058A1 (und)
TW (1) TW200817011A (und)
UY (1) UY30542A1 (und)
WO (1) WO2008020057A1 (und)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
JP5270343B2 (ja) * 2005-08-15 2013-08-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ベータミメティックスの製造方法
CN103501776A (zh) 2011-02-17 2014-01-08 西普拉有限公司 甘罗铵与β2激动剂的组合物
KR20140057604A (ko) 2011-08-12 2014-05-13 베링거잉겔하임베트메디카게엠베하 고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제
WO2014016548A2 (en) * 2012-07-27 2014-01-30 Cipla Limited Pharmaceutical composition
DK2934544T3 (en) 2012-12-21 2019-03-04 Boehringer Ingelheim Vetmedica Gmbh PHARMACEUTICAL FORMULA INCLUDING CICLESONID
CA2888428C (en) 2012-12-21 2021-07-13 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for the treatment of airway disease in horses
ES2759247T3 (es) 2014-06-18 2020-05-08 Boehringer Ingelheim Vetmedica Gmbh Antagonistas muscarínicos y combinaciones de estos para el tratamiento de enfermedades de las vías respiratorias en caballos
EP3359234B1 (de) 2015-10-09 2021-04-28 Boehringer Ingelheim International GmbH Verfahren zur beschichtung mikrostrukturierter bauteile
WO2021150489A1 (en) * 2020-01-20 2021-07-29 Huang Cai Gu Inhalable formulation of a solution containing glycopyrrolate and olodaterol hydrochloride
WO2021262675A1 (en) * 2020-06-23 2021-12-30 Anovent Pharmaceutical (U.S.), Llc Preparation of a pharmaceutical composition of olodaterol, tiotropium bromide and budesonide

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
US6960597B2 (en) * 2000-06-30 2005-11-01 Orth-Mcneil Pharmaceutical, Inc. Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
DE102004019540A1 (de) * 2004-04-22 2005-11-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
SG152237A1 (en) * 2004-04-22 2009-05-29 Boehringer Ingelheim Int Pharmaceutical combinations containing benzoxazine for treating respiratory diseases
US20050239778A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim International Gmbh Novel medicament combinations for the treatment of respiratory diseases
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024454A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1778626A1 (en) * 2004-08-16 2007-05-02 Theravance, Inc. Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
TWI482772B (zh) * 2006-08-21 2015-05-01 Astrazeneca Ab 適合口服且包含三唑并[4,5-d]嘧啶衍生物之組合物

Also Published As

Publication number Publication date
MX2009001759A (es) 2009-02-25
WO2008020057A1 (de) 2008-02-21
BRPI0715761A2 (pt) 2013-09-24
CO6170341A2 (es) 2010-06-18
CA2660488A1 (en) 2008-02-21
KR20090057393A (ko) 2009-06-05
US20120058980A1 (en) 2012-03-08
SG174058A1 (en) 2011-09-29
PE20081319A1 (es) 2008-10-16
IL197025A0 (en) 2009-11-18
NZ575425A (en) 2011-12-22
JP2010501022A (ja) 2010-01-14
AU2007285747A1 (en) 2008-02-21
UY30542A1 (es) 2008-03-31
US20080041369A1 (en) 2008-02-21
AR062425A1 (es) 2008-11-05
NO20090407L (no) 2009-04-29
EP2054084A1 (de) 2009-05-06

Similar Documents

Publication Publication Date Title
TW200817011A (en) Aerosol formulation for the inhalation of beta agonists
JP2010501021A (ja) βアゴニストの吸入用エアロゾル製剤
CA2540174C (en) Aerosol formulation for inhalation, containing an anticholinergic agent
TWI389692B (zh) 用以吸入β-共效劑的氣溶膠調配物
JP2008509197A (ja) 抗コリン作用薬を含む吸入用のエアロゾル製剤
JP2007523119A (ja) ベンジル酸エステル及び可溶性ｔｎｆ受容体融合タンパク質を基にした新規な医薬組成物
TW201420140A (zh) 噴霧劑吸入裝置
JP2009537474A (ja) イプラトロピウムブロマイド及びサルブタモールスルフェートを含有するエアロゾル製剤
JP2010507617A (ja) 呼吸器系及び消化器系障害の治療用の新規な医薬組成物
JP2009514933A (ja) 吸入用エアロゾル製剤
JP2007500150A (ja) 抗コリン作用薬とステロイドとの併用剤及び吸入により呼吸障害を治療するためのその使用
JP2008500278A (ja) フルオレンカルボン酸エステル及び可溶性ｔｎｆ受容体融合タンパク質を基にした新規な医薬組成物
JP2012509299A (ja) β作用薬吸入用のエアロゾル製剤
JP2012509298A (ja) β作用薬吸入用のエアロゾル製剤
CN101505798A (zh) 吸入用β-激动剂的气雾剂
US20060153777A1 (en) Aerosol formulation for inhalation containing an anticholinergic
CN101505728A (zh) 含β-激动剂和类固醇的气雾剂